van Asperen CJ - Search Results

1

Ovarian stimulation for IVF and risk of primary breast cancer in BRCA1/2 mutation carriers.

Derks-Smeets IAP, Schrijver LH, de Die-Smulders CEM, Tjan-Heijnen VCG, van Golde RJT, Smits LJ, Caanen B, van Asperen CJ, Ausems M, Collée M, van Engelen K, Kets CM, van der Kolk L, Oosterwijk JC, van Os TAM; HEBON; Rookus MA, van Leeuwen FE, Gómez García EB. Derks-Smeets IAP, et al. Among authors: van asperen cj, van golde rjt, van der kolk l, van engelen k, van leeuwen fe, van os tam. Br J Cancer. 2018 May 1;119(3):357-363. doi: 10.1038/s41416-018-0139-1. Br J Cancer. 2018. PMID: 29937543 Free PMC article.

2

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

Oldenburg RA, Kroeze-Jansema K, Kraan J, Morreau H, Klijn JG, Hoogerbrugge N, Ligtenberg MJ, van Asperen CJ, Vasen HF, Meijers C, Meijers-Heijboer H, de Bock TH, Cornelisse CJ, Devilee P. Oldenburg RA, et al. Among authors: van asperen cj. Cancer Res. 2003 Dec 1;63(23):8153-7. Cancer Res. 2003. PMID: 14678969

3

Risk estimation for healthy women from breast cancer families: new insights and new strategies.

van Asperen CJ, Jonker MA, Jacobi CE, van Diemen-Homan JE, Bakker E, Breuning MH, van Houwelingen JC, de Bock GH. van Asperen CJ, et al. Among authors: van diemen homan je, van houwelingen jc. Cancer Epidemiol Biomarkers Prev. 2004 Jan;13(1):87-93. doi: 10.1158/1055-9965.epi-03-0090. Cancer Epidemiol Biomarkers Prev. 2004. PMID: 14744738

4

Variants of uncertain clinical significance as a result of BRCA1/2 testing: impact of an ambiguous breast cancer risk message.

van Dijk S, van Asperen CJ, Jacobi CE, Vink GR, Tibben A, Breuning MH, Otten W. van Dijk S, et al. Among authors: van asperen cj. Genet Test. 2004 Fall;8(3):235-9. doi: 10.1089/gte.2004.8.235. Genet Test. 2004. PMID: 15727245

5

What's the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer.

van Dijk S, Otten W, Timmermans DR, van Asperen CJ, Meijers-Heijboer H, Tibben A, Breuning MH, Kievit J. van Dijk S, et al. Among authors: van asperen cj. Genet Med. 2005 Apr;7(4):239-45. doi: 10.1097/01.gim.0000159902.34833.26. Genet Med. 2005. PMID: 15834241 Free article.

6

Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing.

van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Bröcker-Vriends AH, van Asperen CJ, Sijmons RH, Seynaeve C, Van Gool AR, Klijn JG, Tibben A. van Oostrom I, et al. Among authors: van asperen cj, van gool ar. Eur J Cancer. 2007 Jan;43(1):71-7. doi: 10.1016/j.ejca.2006.08.023. Epub 2006 Oct 11. Eur J Cancer. 2007. PMID: 17045473

7

Prediction of BRCA1/2 mutation status in patients with ovarian cancer from a hospital-based cohort.

Jacobi CE, van Ierland Y, van Asperen CJ, Hallensleben E, Devilee P, Jan Fleuren G, Kenter GG. Jacobi CE, et al. Among authors: van asperen cj, van ierland y. Genet Med. 2007 Mar;9(3):173-9. doi: 10.1097/GIM.0b013e318032e4ab. Genet Med. 2007. PMID: 17413421 Free article. Clinical Trial.

8

Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose?

Jacobi CE, de Bock GH, Siegerink B, van Asperen CJ. Jacobi CE, et al. Among authors: van asperen cj. Breast Cancer Res Treat. 2009 May;115(2):381-90. doi: 10.1007/s10549-008-0070-x. Epub 2008 May 30. Breast Cancer Res Treat. 2009. PMID: 18516672

9

A family history of breast cancer will not predict female early onset breast cancer in a population-based setting.

de Bock GH, Jacobi CE, Seynaeve C, Krol-Warmerdam EM, Blom J, van Asperen CJ, Cornelisse CJ, Klijn JG, Devilee P, Tollenaar RA, Brekelmans CT, van Houwelingen JC. de Bock GH, et al. Among authors: van asperen cj, van houwelingen jc. BMC Cancer. 2008 Jul 23;8:203. doi: 10.1186/1471-2407-8-203. BMC Cancer. 2008. PMID: 18651949 Free PMC article.

10

Genome-wide linkage scan in Dutch hereditary non-BRCA1/2 breast cancer families identifies 9q21-22 as a putative breast cancer susceptibility locus.

Oldenburg RA, Kroeze-Jansema KH, Houwing-Duistermaat JJ, Bayley JP, Dambrot C, van Asperen CJ, van den Ouweland AM, Bakker B, van Beers EH, Nederlof PM, Vasen H, Hoogerbrugge N, Cornelisse CJ, Meijers-Heijboer H, Devilee P. Oldenburg RA, et al. Among authors: van asperen cj, van den ouweland am, van beers eh. Genes Chromosomes Cancer. 2008 Nov;47(11):947-56. doi: 10.1002/gcc.20597. Genes Chromosomes Cancer. 2008. PMID: 18663745

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

220 results

Search Page